SEC Form 4 · accession 0001144204-15-023715
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin C Johnson
Director
Period of report
Apr 16, 2015
Accepted (ET)
Apr 20, 2015 · 12:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 16, 2015 | A | 2,080 | $4.82 | A | 95,747 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Johnson received 2,080 restricted shares on April 16, 2015 for his service on the board of directors. The shares will vest ratably over the next four quarters at 520 shares per quarter for service on the board of directors.